Crossmark

Cost-effectiveness of RefluxStop compared to proton pump inhibitors and Nissen fundoplication for management of persistent gastroesophageal reflux disease in Norway

Crossref DOI link: https://doi.org/10.1186/s12962-025-00665-1

Published Online: 2025-10-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Harper, Sam

Kartha, Muralikrishnan

Mealing, Stuart

Eftang, Lars

Gaupset, Robin
License Information

Text and Data Mining valid from 2025-10-29

Version of Record valid from 2025-10-29
More Information

Article History

Received: 26 June 2024

Accepted: 29 September 2025

First Online: 29 October 2025

Declarations

:

: Ethics approval and consent for participation were not required for this study.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below